Warren Buffett’s Berkshire Hathaway deployed $3.2 billion into equities last quarter, with $1.8 billion spread across seven ...

AbbVie got a shiny new price target of $204 from Bank of America, yet analysts aren’t exactly throwing a party. Eight ...

Merck’s stock showed a slight pulse this week, with a 0.41% daily rise and a 4.31% gain over five days, prompting cautious ...

Annual Meeting gave shareholders plenty to chew on—without any need for corporate antacids. The company approved a major update to its 2013 Equity Incentive Plan, adding 34 million new shares and ...

Bank of America has secured a “Moderate Buy” rating from 27 analysts, mostly leaning toward optimism despite a few skeptics.

Advanced Micro Devices just lit a fire under its stock, surging over 3% and keeping its bullish streak alive. The rise is ...

First City Capital Management trimmed its Chevron holdings by 26.2%, selling nearly 5,000 shares and reducing its exposure to ...

Netflix director Jay C. Hoag just pulled off the financial equivalent of a dramatic season finale by selling 31,750 shares ...

Morgan Stanley has once again backed Coca-Cola with an “Overweight” rating and a price target of $81, signaling continued ...

Olstein Capital Management has made a fizzy move, snapping up 21,000 shares of PepsiCo worth over $3.1 million in Q1. Several ...

Adobe is set to report earnings on June 12, 2025, and historically, that hasn’t gone so well for the stock. In 70% of the ...

Thermo Fisher Scientific saw a modest 1.35% gain, closing at $407.31, but that tiny uptick can’t disguise the stock’s ...